Principal Financial Group Inc Voyager Therapeutics, Inc. Transaction History

Principal Financial Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$2.47 - $5.55 $182,780 - $410,700	-74,000 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$2.63 - $4.12 $1,457 - $2,282	-554 Reduced 0.74%	74,000 $195,000
Q2 2021 Aug 10, 2021	BUY	$3.94 - $5.44 $191,030 - $263,758	48,485 Added 185.99%	74,554 $307,000
Q1 2021 May 10, 2021	BUY	$4.61 - $9.04 $9,183 - $18,007	1,992 Added 8.27%	26,069 $123,000
Q4 2020 Feb 08, 2021	BUY	$7.15 - $12.28 $172,150 - $295,665	24,077 New	24,077 $172,000

118

32.6M

32.9K

22.7K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $180M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.